Cargando…

Artificial Intelligence and Antibiotic Discovery

Over recent decades, a new antibiotic crisis has been unfolding due to a decreased research in this domain, a low return of investment for the companies that developed the drug, a lengthy and difficult research process, a low success rate for candidate molecules, an increased use of antibiotics in f...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Liliana, Brata, Anca Monica, Mogosan, Cristina, Pop, Cristina, Czako, Zoltan, Muresan, Lucian, Ismaiel, Abdulrahman, Dumitrascu, Dinu Iuliu, Leucuta, Daniel Corneliu, Stanculete, Mihaela Fadygas, Iaru, Irina, Popa, Stefan Lucian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614913/
https://www.ncbi.nlm.nih.gov/pubmed/34827314
http://dx.doi.org/10.3390/antibiotics10111376
_version_ 1784603976328544256
author David, Liliana
Brata, Anca Monica
Mogosan, Cristina
Pop, Cristina
Czako, Zoltan
Muresan, Lucian
Ismaiel, Abdulrahman
Dumitrascu, Dinu Iuliu
Leucuta, Daniel Corneliu
Stanculete, Mihaela Fadygas
Iaru, Irina
Popa, Stefan Lucian
author_facet David, Liliana
Brata, Anca Monica
Mogosan, Cristina
Pop, Cristina
Czako, Zoltan
Muresan, Lucian
Ismaiel, Abdulrahman
Dumitrascu, Dinu Iuliu
Leucuta, Daniel Corneliu
Stanculete, Mihaela Fadygas
Iaru, Irina
Popa, Stefan Lucian
author_sort David, Liliana
collection PubMed
description Over recent decades, a new antibiotic crisis has been unfolding due to a decreased research in this domain, a low return of investment for the companies that developed the drug, a lengthy and difficult research process, a low success rate for candidate molecules, an increased use of antibiotics in farms and an overall inappropriate use of antibiotics. This has led to a series of pathogens developing antibiotic resistance, which poses severe threats to public health systems while also driving up the costs of hospitalization and treatment. Moreover, without proper action and collaboration between academic and health institutions, a catastrophic trend might develop, with the possibility of returning to a pre-antibiotic era. Nevertheless, new emerging AI-based technologies have started to enter the field of antibiotic and drug development, offering a new perspective to an ever-growing problem. Cheaper and faster research can be achieved through algorithms that identify hit compounds, thereby further accelerating the development of new antibiotics, which represents a vital step in solving the current antibiotic crisis. The aim of this review is to provide an extended overview of the current artificial intelligence-based technologies that are used for antibiotic discovery, together with their technological and economic impact on the industrial sector.
format Online
Article
Text
id pubmed-8614913
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86149132021-11-26 Artificial Intelligence and Antibiotic Discovery David, Liliana Brata, Anca Monica Mogosan, Cristina Pop, Cristina Czako, Zoltan Muresan, Lucian Ismaiel, Abdulrahman Dumitrascu, Dinu Iuliu Leucuta, Daniel Corneliu Stanculete, Mihaela Fadygas Iaru, Irina Popa, Stefan Lucian Antibiotics (Basel) Review Over recent decades, a new antibiotic crisis has been unfolding due to a decreased research in this domain, a low return of investment for the companies that developed the drug, a lengthy and difficult research process, a low success rate for candidate molecules, an increased use of antibiotics in farms and an overall inappropriate use of antibiotics. This has led to a series of pathogens developing antibiotic resistance, which poses severe threats to public health systems while also driving up the costs of hospitalization and treatment. Moreover, without proper action and collaboration between academic and health institutions, a catastrophic trend might develop, with the possibility of returning to a pre-antibiotic era. Nevertheless, new emerging AI-based technologies have started to enter the field of antibiotic and drug development, offering a new perspective to an ever-growing problem. Cheaper and faster research can be achieved through algorithms that identify hit compounds, thereby further accelerating the development of new antibiotics, which represents a vital step in solving the current antibiotic crisis. The aim of this review is to provide an extended overview of the current artificial intelligence-based technologies that are used for antibiotic discovery, together with their technological and economic impact on the industrial sector. MDPI 2021-11-10 /pmc/articles/PMC8614913/ /pubmed/34827314 http://dx.doi.org/10.3390/antibiotics10111376 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
David, Liliana
Brata, Anca Monica
Mogosan, Cristina
Pop, Cristina
Czako, Zoltan
Muresan, Lucian
Ismaiel, Abdulrahman
Dumitrascu, Dinu Iuliu
Leucuta, Daniel Corneliu
Stanculete, Mihaela Fadygas
Iaru, Irina
Popa, Stefan Lucian
Artificial Intelligence and Antibiotic Discovery
title Artificial Intelligence and Antibiotic Discovery
title_full Artificial Intelligence and Antibiotic Discovery
title_fullStr Artificial Intelligence and Antibiotic Discovery
title_full_unstemmed Artificial Intelligence and Antibiotic Discovery
title_short Artificial Intelligence and Antibiotic Discovery
title_sort artificial intelligence and antibiotic discovery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614913/
https://www.ncbi.nlm.nih.gov/pubmed/34827314
http://dx.doi.org/10.3390/antibiotics10111376
work_keys_str_mv AT davidliliana artificialintelligenceandantibioticdiscovery
AT brataancamonica artificialintelligenceandantibioticdiscovery
AT mogosancristina artificialintelligenceandantibioticdiscovery
AT popcristina artificialintelligenceandantibioticdiscovery
AT czakozoltan artificialintelligenceandantibioticdiscovery
AT muresanlucian artificialintelligenceandantibioticdiscovery
AT ismaielabdulrahman artificialintelligenceandantibioticdiscovery
AT dumitrascudinuiuliu artificialintelligenceandantibioticdiscovery
AT leucutadanielcorneliu artificialintelligenceandantibioticdiscovery
AT stanculetemihaelafadygas artificialintelligenceandantibioticdiscovery
AT iaruirina artificialintelligenceandantibioticdiscovery
AT popastefanlucian artificialintelligenceandantibioticdiscovery